Through multiple linear regression analysis of Egr3 expression in specific cell types (tumor, stroma, BPH) we were also able to show that Egr3 mRNA is up-regulated in prostate cancer of men with less aggressive disease (non-relapse) but not in men who will eventually go on to relapse. This evidence concerns the gene EGR3 and Familial prostate cancer.